Medical specialists from Canada tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 59 results
-
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Anand V Sahai, MDSeen in:
- Quebec, Montreal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Trials:- NCT04951804 (Principal Investigator)
Conditions: -
Anne-Julie SimardSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Arif AwanSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, University of Ottawa / Ottawa General Hospital
Trials:- NCT05571839 (Principal Investigator)
- NCT04609566 (Principal Investigator)
- NCT05194072 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT05229900 (Principal Investigator)
Conditions:- Colorectal Neoplasms;
- Pancreatic Neoplasms;
- Mesothelioma;
- Non-small Cell Lung Cancer;
- Cutaneous Melanoma;
- Melanoma;
- Squamous Cell Carcinoma of the Head and Neck;
- Carcinoma, Non-Small-Cell Lung;
- Adenoid Cystic Carcinoma;
- Ovarian Neoplasms;
- Fallopian Tube Neoplasms;
- Peritoneal Neoplasms;
- Endometrial Neoplasms;
- Cholangiocarcinoma;
- Triple Negative Breast Neoplasms;
- Gallbladder Carcinoma;
- HER2 Negative Breast Neoplasms;
- Hormone Receptor Positive Breast Neoplasms;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Esophageal Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Testicular Neoplasms
-
Aruz MesciSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT05687123 (Principal Investigator)
-
Carl Daigle, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Christina KimSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04340141 (Principal Investigator)
-
Daniel J. RenoufSeen in:
- British Columbia, Vancouver, BCCA-Vancouver Cancer Centre
Trials:- NCT04340141 (Principal Investigator)
-
Daniel Renouf, MD, MPHSeen in:
- British Columbia, Vancouver, British Columbia Cancer
Trials:- NCT05132244 (Principal Investigator)
-
David Laidley, MDSeen in:
- Ontario, London, London Health Sciences Centre
Trials:- NCT05477576 (Principal Investigator)
-
Derek JonkerSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, Ottawa Hospital Cancer Centre (OHRI)
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Diane ProvencherSeen in:
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal
- Quebec, Montréal, Centre hospitalier de l'Université de Montréal (CHUM)
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Erica TsangSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT05411094 (Principal Investigator)
-
Félix Couture, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Frederic LemaySeen in:
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
- Quebec, Sherbrooke, GSK Investigational Site
Trials:- NCT04068103 (Principal Investigator)
- NCT04340141 (Principal Investigator)
- NCT05723562 (Principal Investigator)
- NCT03678883 (Principal Investigator)
Conditions:- Colon Adenocarcinoma;
- Stage IIA Colon Cancer AJCC v8;
- Pancreatic Cancer;
- Pancreatic Adenosquamous Carcinoma;
- Resectable Pancreatic Adenocarcinoma;
- Neoplasms, Rectal;
- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
George ZogopoulosSeen in:
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montreal, The Research Institute of the McGill University Health Centre (MUHC)
- Quebec, Montréal, McGill University Health Centre
Trials:- NCT04970056 (Principal Investigator)
- NCT04340141 (Principal Investigator)
- NCT04104230 (Principal Investigator)
- NCT04318834 (Principal Investigator)
Conditions:- Pancreatic Ductal Adenocarcinoma;
- Pancreas Cancer;
- Genetic Predisposition;
- Pancreas Cyst;
- Pancreatic Cancer;
- Pancreatic Adenosquamous Carcinoma;
- Resectable Pancreatic Adenocarcinoma;
- Bile Duct Cancer;
- Gallbladder Cancer;
- Pancreas Neoplasm;
- Familial Pancreatic Cancer;
- Duodenal Cancer;
- Hereditary Cancer;
- Ampullary Cancer;
- Pancreatic Precancerous Condition;
- Biliary Tract Cancer
-
Guillaume MartelSeen in:
- Ontario, Ottawa, Ottawa Hospital and Cancer Center-General Campus
Trials:- NCT04340141 (Principal Investigator)
-
Holger HirteSeen in:
- Ontario, Hamilton, Juravinski Cancer Center
Trials:- NCT02632448 (Principal Investigator)
-
Howard Lim, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT03450018 (Sub-Investigator)
- NCT02869802 (Sub-Investigator)
-
Intan SchraderSeen in:
- British Columbia, Vancouver, British Columbia Cancer Agency
Trials:- NCT04970056 (Principal Investigator)
-
Isabelle Deshaies, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Jamil Asselah, MDSeen in:
- Quebec, Montréal, McGill University Health Centre
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Janine M Davies, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT02869802 (Sub-Investigator)
Conditions: -
Jean-François Berthin Ouellet, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Jean-Francois OuelletSeen in:
- Quebec, Quebec City, CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
- Quebec, Quebec City, CHU de Québec
Trials:- NCT04340141 (Principal Investigator)
- NCT06349278 (Sub-Investigator)
-
Jennifer L Spratlin, MD FRCPCSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT01586611 (Sub-Investigator)
Conditions: -
Karen King, MC FRCPCSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT01586611 (Principal Investigator)
Conditions:
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of OxfordNational Institute for Health Research, United Kingdom; ImunonWithdrawnPancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Non-resectableUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAdvanced Pancreatic Carcinoma | Metastatic Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma | Pancreatic Neoplasm | Locally Advanced Pancreatic CarcinomaUnited States